Gland Pharma Limited has informed the Exchange about Schedule of meet
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gland Pharma has informed the stock exchanges about an upcoming meeting with Ventura Securities scheduled for March 23, 2026. The meeting will be a one-on-one session with the institutional investor/analyst. This is a routine disclosure filed under SEBI's listing regulations. The company has noted that the schedule may change due to unforeseen circumstances on either side.
This is a standard investor engagement disclosure with no material business impact. Shareholders should watch for any price-sensitive information that may emerge from the meeting, but single broker meetings are typically routine and unlikely to move the stock significantly.